PARP1 and neoplasm: Currently there is an abundance of preclinical evidence which supports the theory that Ewing’s sarcoma gene fusions depend on PARP1 activity and that tumor cell lines harboring these fusions are extremely vulnerable to PARP blocking (Brenner et al., 2012).